Treatment.Com International Overview
Get informed when a big investor buys or sells
+ Follow-108.15%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for TRUE.CN is -108.15%. That is below the sector sector average of 11.64%. Investors often review this figure alongside Treatment.Com International's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, TRUE.CN currently prints -108.15% for ROE, while the sector average sits near 11.64%. That is roughly 1029.4% below the sector mean. Large gaps often invite a closer look at Treatment.Com International's growth, margins, and balance sheet.
Return on Equity shows how effectively Treatment.Com International converts resources into returns. At -108.15%, TRUE.CN may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting TRUE.CN's ROE (-108.15%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
